Search

Your search keyword '"Pfizer Inc. -- Reports"' showing total 262 results
Start Over Descriptor "Pfizer Inc. -- Reports" Journal plus company updates
262 results on '"Pfizer Inc. -- Reports"'

1. Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsight

Subjects
Bayer AG -- Reports, Pfizer Inc. -- Reports, Regeneron Pharmaceuticals Inc. -- Reports, AstraZeneca PLC -- Reports, Eli Lilly and Co. -- Reports, Business -- Research, Prostate cancer -- Reports, Metastasis -- Reports, Clinical trials -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following press release: DelveInsight's 'Metastatic Castration-Sensitive Prostate Cancer Pipeline Insight 2024' report provides comprehensive global coverage of pipeline mCSPC therapies in [...]

Published
2024

3. Psychedelic Therapeutics Clinical Trials Research Report 2024 Featuring Yale University, Johnson & Johnson, Shire Pharmaceuticals, Pfizer, Lykos, and UCB

Subjects
Shire Pharmaceuticals Group Ltd. -- Reports, Johnson & Johnson -- Reports, Pfizer Inc. -- Reports, Yale University -- Reports, Reports, Clinical trials -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Clinical Trials: Psychedelic Therapeutics' report has been added to ResearchAndMarkets.com's offering. This report provides a review of global psychedelic [...]

Published
2024

4. The Corporate Reputation of Pharma in the UK: Survey Results from 87 UK Patient Groups

Subjects
Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition' report has been added to ResearchAndMarkets.com's [...]

Published
2024

5. Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies - Novo Nordisk A|S, Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Rhythm Pharmaceuticals, Harmony Biosciences

Subjects
Pfizer Inc. -- Reports, Boehringer Ingelheim GmbH -- Reports, Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Obesity -- Reports, Patient compliance -- Reports, Liraglutide -- Reports, Type 2 diabetes -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Obesity Market Insights report includes a comprehensive understanding of current treatment practices, obesity emerging drugs, market share [...]

Published
2024

7. Global COVID-19 Vaccines Strategic Research Report 2024

Subjects
Pfizer Inc. -- Reports, Moderna Inc. -- Reports, AstraZeneca PLC -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Biotechnology industry -- Reports, Vaccines -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'COVID-19 Vaccines - Global Strategic Business Report' has been added to ResearchAndMarkets.com's offering. Global COVID-19 Vaccines Market to Reach [...]

Published
2024

8. United States Non-small Cell Lung Cancer Digital Marketing Analysis Report 2023: Merck's Keytruda.com Achieved the Highest Total Traffic, Followed by BMS's Opdivo.com and AstraZeneca's Imfinzi.com

Subjects
Merck & Company Inc. -- Reports, Pfizer Inc. -- Reports, AstraZeneca PLC -- Reports, Lung cancer, Small cell -- Reports, Electronic marketing -- Reports, Lung cancer, Non-small cell -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

Dublin: Research and Markets has issued the following news release: The 'United States Digital Marketing Trends in Non-small Cell Lung Cancer' report has been added to ResearchAndMarkets.com's offering. This report [...]

Published
2024

10. United States Biosimilar industry Outlook to 2028, Featuring Pfizer, Amgen, Biogen, Viatris and Coherus Biosciences

Subjects
Pfizer Inc. -- Reports, Biological products industry -- Industry forecasts, Chronic diseases -- Reports, Pharmaceutical industry -- Industry forecasts, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'US Biosimilar industry outlook to 2028' report has been added to ResearchAndMarkets.com's offering. The US Biosimilar Industry is anticipated [...]

Published
2024

11. Small Molecule API Market Size, Share & Growth Analysis, [2030] | With CAGR of 6.8%

Subjects
Pfizer Inc. -- Reports, Chronic diseases -- Drug therapy, Drug approval -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

Pune: Fortune Business Insights has issued the following press release: The small molecule API market size is projected to grow from USD 154.95 billion in 2023 to USD 246.22 billion [...]

Published
2023

13. ADC market revenue to reach $29.6b

Subjects
ADC Therapeutics S.A. -- Reports, Pfizer Inc. -- Reports, ImmunoGen Inc. -- Reports, Insight Partners -- Reports, Antineoplastic agents -- Reports, Biological products -- Reports, Cancer -- Care and treatment, Venture capital companies -- Reports, Monoclonal antibodies -- Reports, Pharmaceutical industry -- Reports, Antimitotic agents -- Reports, General interest, News, opinion and commentary
Abstract

Pune: Antibody drug conjugates (ADC) are one of the fastest growing anticancer drugs. It is typically composed of a monoclonal antibody (mAbs) covalently attached to a cytotoxic drug via a [...]

Published
2023

14. Trigeminal Neuralgia Drug Pipeline Research Report 2023: Comprehensive Insights on 10 Companies and 10 Pipeline Drugs Featuring Biogen, Biohaven Pharmaceuticals, Noema Pharma, & Pfizer

Subjects
Pfizer Inc. -- Reports, Biological products industry -- Reports, Neuralgia, Trigeminal -- Reports, Homeopathy -- Materia medica and therapeutics, Drugs -- Reports, Therapeutics -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Trigeminal Neuralgia - Pipeline Insight, 2023' clinical trials has been added to ResearchAndMarkets.com's offering. The 'Trigeminal Neuralgia- Pipeline Insight, [...]

Published
2023

15. Pfizer invites investors to view & listen to webcast on August 1s

Subjects
Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

NEW YORK: Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT [...]

Published
2023

16. Significant Positive Shift in the Cell and Gene Therapies in Rare Disorders Market with 35.8% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight

Subjects
Johnson & Johnson -- Reports, Pfizer Inc. -- Reports, Applied Genetic Technologies Corp. -- Reports, Business -- Research, Genes -- Reports, Biotechnology industry -- Reports, Gene therapy -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Cell and Gene Therapies in Rare Disorders Market Insights report includes a comprehensive understanding of current treatment [...]

Published
2023

17. At 9.1% CAGR, Global Perilymph Fistula Treatment Market Size to Hit USD 22.03 Billion by 2030 | Perilymph Fistula Treatment Industry Trends, Share, Price, Demand, Analysis & Forecast Report by Zion Market Research

Subjects
Pfizer Inc. -- Reports, Fistula -- Reports, Marketing research -- Reports, Head injuries -- Reports, General interest, News, opinion and commentary
Abstract

NEW YORK: Zion Market Research has issued the following news release: Zion Market Research has published a new research report titled 'Perilymph Fistula Treatment Market By Symptoms (Tinnitus, Hearing Loss, [...]

Published
2023

18. Pharmaceutical Multinationals Continue To Spurn The Opportunity To Connect Via Social Media At A Local Level

Subjects
Pfizer Inc. -- Reports, Novartis AG -- Reports, International cooperation -- Reports, Social media -- Reports, Health care industry -- Reports, International business enterprises -- Reports, Pharmaceutical industry -- Reports, Health care industry, General interest, News, opinion and commentary, Facebook (Online social network) -- Reports
Abstract

NEW YORK: THE WORLDCOM PUBLIC RELATIONS GROUP has issued the following news release: The Worldcom Public Relations Group, the leading global partnership of independent public relations firms, released today The [...]

Published
2023

19. Pfizer Invites Public to View & Listen to Webcast of May 2 Conference Call with Analysts

Subjects
Pfizer Inc. -- Reports, Health care industry -- Reports, Pharmaceutical industry -- Reports, Health care industry, General interest, News, opinion and commentary
Abstract

NEW YORK: Pfizer Inc., invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, [...]

Published
2023

20. Phase 3 Study Shows XTANDI(r) (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer

Subjects
Astellas Pharma Inc. -- Reports, Pfizer Inc. -- Reports, Prostate cancer -- Research, Metastasis -- Research, Pharmaceutical industry -- Reports -- Research, General interest, News, opinion and commentary, Xtandi (Medication) -- Research -- Reports
Abstract

NEW YORK: Astellas Pharma Inc.; Pfizer Inc. has issued the following news release: Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., 'Astellas') [...]

Published
2023

21. US Neurologists Cautiously Optimistic About Potential Approval of Pfizer's Zavegepant for the Acute Treatment of Migraine, According to Spherix Global Insights

Subjects
Pfizer Inc. -- Reports, Migraine -- Drug therapy, Drug approval -- Reports, General interest, News, opinion and commentary, Trudhesa (Medication) -- Reports
Abstract

EXTON: Spherix Global Insights has issued the following news release: On February 16, The Lancet Neurology published the Phase 3 results of Pfizer's zavegepant for the acute treatment of migraine. [...]

Published
2023

22. Reportlinker.com announces release of report

Subjects
Hoffmann-La Roche AG -- Reports, Johnson & Johnson -- Reports, Bayer AG -- Reports, Pfizer Inc. -- Reports, AstraZeneca PLC -- Reports, Sanofi S.A. -- Reports, Biological products industry -- Reports, Prostate cancer -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

New York: Reportlinker.com announces the release of the report 'Prostate Cancer Drugs Global Market Report 2023' - https://www.reportlinker.com/p06245030/?utm_source=GNW Major players in the prostate cancer drugs market are Astellas Inc., AstraZeneca [...]

Published
2023

23. report on the global market for contraceptives in 2023

Subjects
Merck & Company Inc. -- Reports, Bayer AG -- Reports, Pfizer Inc. -- Reports, Contraceptives industry -- Reports, Pharmaceutical industry -- Reports, Oral contraceptives -- Reports, General interest, News, opinion and commentary
Abstract

NEW YORK: The global hormonal contraceptives market is expected to grow from $13.47 billion in 2022 to $13.78 billion in 2023 at a compound annual growth rate (CAGR) of 2.3%. [...]

Published
2023

24. Global RNA Vaccine Advances Research Report 2022: Overcoming RNA Vaccine Manufacturing Bottlenecks to Meet Increased Demand

Subjects
Pfizer Inc. -- Reports, Biological products industry -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Messenger RNA -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Advances and Growth Opportunities in RNA Vaccines' report has been added to ResearchAndMarkets.com's offering. RNA therapeutics and vaccines have [...]

Published
2023

25. Views of 258 Neurology Patient Groups on the Corporate Reputation of Pharma in 2022

Subjects
Pfizer Inc. -- Reports, Novartis AG -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology [...]

Published
2023

26. The Corporate Reputation of Pharma Companies in Canada, 2021-2022 from The Patient Perspective - Focus on R&D, Transparency, Drug pricing, Patient Access to Medicines

Subjects
Pfizer Inc. -- Reports, Pricing -- Reports -- Surveys, Drugs -- Surveys -- Reports, Pharmaceutical industry -- Reports -- Surveys, Product price, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 [...]

Published
2023

27. The Views of 300 Asian Patient Groups on the Corporate Reputation of Pharma, 2021-2022

Subjects
Gilead Sciences Inc. -- Reports, Pfizer Inc. -- Reports, Biological products industry -- Reports -- Surveys, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 [...]

Published
2023

28. Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma

Subjects
Pfizer Inc. -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German [...]

Published
2023

29. The Views of 103 Italian Patient Groups on the Corporate Reputation of Pharma, 2021-2022

Subjects
Pfizer Inc. -- Reports, Novartis AG -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian [...]

Published
2023

30. The Corporate Reputation of Pharma Companies in Canada, 2021-2022: AbbVie, Roche, BMS, Sanofi, Pfizer, Merck, Bayer and Amgen Made the Biggest Rises

Subjects
Bayer AG -- Reports, Pfizer Inc. -- Reports, Sanofi S.A. -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 [...]

Published
2023

31. Patient Perspective of the Corporate Reputation of Pharma in 2021-2022: Focus on Chiesi Farmaceutici, AbbVie, Bayer, Eli Lilly, GSK, Merck, Mylan, Novartis, Pfizer, Roche, Sanofi, Teva Among Others

Subjects
Pfizer Inc. -- Reports, Sanofi S.A. -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 [...]

Published
2023

32. Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: The Views of 293 Patient Groups with 138 of these Respondent Patient Groups Specialised in Arthritis

Subjects
Pfizer Inc. -- Reports, Arthritis -- Surveys -- Reports, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient [...]

Published
2023

33. Corporate Reputation of Pharma in United States, 2021-2022 Report

Subjects
Acorda Therapeutics Inc. -- Reports, Pfizer Inc. -- Reports, Biological products industry -- Reports -- Surveys, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

Dublin: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA Edition - The Views of 240 USA Patient Groups' report has been added to ResearchAndMarkets.com's [...]

Published
2023

34. Corporate Reputation of Global Pharma Companies, 2021-2022: Get The Patient Perspective from 2,150 Patient Groups

Subjects
Acorda Therapeutics Inc. -- Reports, Pfizer Inc. -- Reports, Gilead Sciences Inc. -- Reports, Biological products industry -- Reports -- Surveys, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Global Edition' report has been added to [...]

Published
2023

36. General Motors and these 2 healthcare majors on CNBC's 'Final Trades'

Subjects
CNBC L.L.C. -- Reports, General Motors Co. -- Reports, Pfizer Inc. -- Reports, Eli Lilly and Co. -- Reports, Cable television broadcasting industry -- Reports, Automobile industry -- Reports, Pharmaceutical industry -- Reports, Automobile Industry, General interest, News, opinion and commentary
Abstract

In CNBC's 'Halftime Report Final Trades,' Bryn Talkington of Requisite Capital Management named Pfizer Inc. PFE, saying it offers 'growth at a reasonable price'. Analyst ratings data from Benzinga shows [...]

Published
2023

37. The Corporate Reputation of Pharma in 2021-2022: Rankings of 30 Companies - The Patient Perspective of 520 Cancer Patient Groups

Subjects
Pfizer Inc. -- Reports, Cancer patients -- Surveys -- Care and treatment, Pharmaceutical industry -- Reports -- Surveys, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 [...]

Published
2023

39. Propulsion of Nonalcoholic Steatohepatitis Pipeline as Novel and Extensive 150+ Therapies Likely to Enter in the Treatment Domain | DelveInsight

Subjects
Novartis Pharma AG -- Reports, Bristol-Myers Squibb Co. -- Reports, Gilead Sciences Inc. -- Reports, Pfizer Inc. -- Reports, Boehringer Ingelheim GmbH -- Reports, AstraZeneca PLC -- Reports, Biological products industry -- Reports, Business -- Research, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research LLP has issued the following news release: DelveInsight's 'Nonalcoholic Steatohepatitis Pipeline Insight - 2022' report provides comprehensive global coverage of available, marketed, and pipeline nonalcoholic [...]

Published
2022

40. Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate

Subjects
Pfizer Inc. -- Reports, Valneva SE -- Reports, Euronext Paris S.A. -- Reports, Vaccination -- Reports, Pediatrics -- Reports, Biotechnology industry -- Reports, Vaccines -- Reports, Lyme disease -- Reports, Securities industry -- Reports, Pharmaceutical industry -- Reports, Securities industry, General interest, News, opinion and commentary
Abstract

New York: VALNEVA has issued the following news release: Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today reported antibody persistence data six months after the [...]

Published
2022

41. Pfizer|Bristol Myers blood-clotting drug doesn't help COVID-19 patients, UK study finds

Subjects
Pfizer Inc. -- Reports, Bristol-Myers Squibb Co. -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Arrhythmia -- Research, Apixaban -- Research, Pharmaceutical industry -- Reports -- Research, General interest, News, opinion and commentary
Abstract

Eliquis (apixaban), widely prescribed for COVID-19, did not help patients recovering from moderate and severe COVID, according to a UK study. A drug used after hospital discharge does not reduce [...]

Published
2022

42. Parkinson's Disease Drug Market is Pegged to Reach $12.3 Billion By 2028 | Levodopa is the Most Popular Drug

Subjects
Pfizer Inc. -- Reports, Rasagiline -- Health aspects -- Reports, Pharmaceutical industry -- Reports -- Health aspects, General interest, News, opinion and commentary
Abstract

Westford: SkyQuest Technology Consulting Pvt. Ltd. has issued the following press release: Parkinson's disease is a debilitating neurological disorder that affects millions of people worldwide. As the population ages, the [...]

Published
2022

43. Insights into the Rheumatoid Arthritis (RA) Online Space, 2022 Report Featuring UCB, Galapagos, BMS, Amgen, Pfizer, Sanofi, AbbVie, Genentech, Janssen, & Eli Lilly

Subjects
Pfizer Inc. -- Reports, Eli Lilly and Co. -- Reports, Sanofi S.A. -- Reports, Biological products industry -- Reports, Rheumatoid factor -- Reports, Arthritis -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Rheumatoid Arthritis (RA) Therapy Area Report' report has been added to ResearchAndMarkets.com's offering. This latest report offers fresh insights [...]

Published
2022

45. ICON Releases its 2021 ESG Report

Subjects
BioNTech SE -- Reports, Pfizer Inc. -- Reports, ICON PLC -- Reports, Medical research -- Social aspects -- Reports, Medicine, Experimental -- Social aspects -- Reports, Biotechnology industry -- Social aspects -- Reports, Pharmaceutical industry -- Reports -- Social aspects, General interest, News, opinion and commentary
Abstract

DUBLIN: ICON plc has issued the following news release: ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its 2021 Environmental, Social and Governance (ESG) [...]

Published
2022

46. 2022 Hidradenitis Suppurativa Pipeline Insight Report - Featuring Janssen Biotech, AbbVie and Pfizer Among Others

Subjects
Pfizer Inc. -- Reports, Biotechnology -- Reports, Pharmaceutical industry -- Reports, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Hidradenitis Suppurativa - Pipeline Insight, 2022' clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights [...]

Published
2022

48. Worldwide Lung Cancer Antibodies Market to 2028 - Featuring Pfizer, Roche and Samsung Bio Among Others

Subjects
Pfizer Inc. -- Reports, Biological products -- Reports, Viral antibodies -- Reports, Immunotherapy -- Reports, Lung cancer -- Reports, Antibodies -- Reports, Industrial research -- United States, Pharmaceutical industry -- Reports, Research and development, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2022

49. Varicella Vaccines Market is projected 6.3% CAGR during the 2022-2032 forecast period - Future Market Insights, Inc

Subjects
Pfizer Inc. -- Reports, Biological products industry -- Industry forecasts, Chickenpox -- Reports, Vaccines -- Reports, Industrial research -- United States, Pharmaceutical industry -- Industry forecasts, Research and development, General interest, News, opinion and commentary
Abstract

NEWARK: Future Market Insights Global and Consulting Pvt. Ltd. has issued the following press release: A recently published Future Market Insights report forecasts that the market for varicella vaccines is [...]

Published
2022

50. Global Kidney Cancer Market Forecast to 2028 - Abbvie, Bayer Pharma, Merck & Co, GlaxoSmithKline, and Pfizer Are Dominating the Industry

Subjects
Merck & Company Inc. -- Reports, AbbVie Inc. -- Reports, Pfizer Inc. -- Reports, Bayer HealthCare Pharmaceuticals -- Reports, GlaxoSmithKline PLC -- Reports, Kidney cancer -- Reports -- Health aspects, Cancer -- Health aspects -- Reports, Pharmaceutical industry -- Industry forecasts, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Kidney Cancer Market 2022-2028' report has been added to ResearchAndMarkets.com's offering. The global kidney cancer market is anticipated [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results